CareDx, Inc. (CDNA) vs GRAIL, Inc. (GRAL)
- CareDx, Inc. CDNA 63.81 −4.30%
- GRAIL, Inc. GRAL 117.81 −13.03%
CareDx, Inc. and GRAIL, Inc. are both Diagnostics & Research companies. GRAIL, Inc. is the larger, with a market value of $6.1B against $3.5B — 1.8× the size. GRAIL, Inc. has negative trailing earnings, so its P/E is not meaningful; CareDx, Inc. trades at 29.7×. CareDx, Inc. grew revenue faster over the last twelve months: 34.4% against 23.1%. CareDx, Inc. has the higher net margin (24.2% vs −237.0%) and the higher return on invested capital (130.1% vs −20.8%). Across the 16 metrics below, CareDx, Inc. leads on 12 and GRAIL, Inc. on 4.
Valuation
Profitability
| Metric | CDNA | GRAL | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 70.58% | (31.31%) | 50.89% |
| Operating margin | 23.61% | (338.40%) | (8.57%) |
| Net margin | 24.23% | (236.95%) | (6.37%) |
| Free cash flow margin | 18.49% | (179.21%) | 0.00% |
| Return on equity | 29.49% | (16.12%) | (2.92%) |
| Return on assets | 22.72% | (14.12%) | (6.71%) |
| Return on invested capital | 130.06% | (20.79%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack